SPC25 may promote proliferation and metastasis of hepatocellular carcinoma via p53

被引:15
|
作者
Chen, Fengjuan [1 ,2 ]
Zhang, Ka [3 ]
Huang, Yilin [4 ]
Luo, Fang [1 ]
Hu, Kunpeng [5 ]
Cai, Qingxian [1 ]
机构
[1] Third Peoples Hosp Shenzhen, Dept Hepatol, 29 Bulan Rd, Shenzhen 518112, Peoples R China
[2] Guangzhou Eighth Peoples Hosp, Dept Hepatol, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Dept Infect Dis, Affiliated Hosp 3, Guangzhou, Peoples R China
[4] Guangdong Prov Peoples Hosp, Dept Rehabil, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ, Dept Gen Surg, Affiliated Hosp 3, Guangzhou 510000, Peoples R China
来源
FEBS OPEN BIO | 2020年 / 10卷 / 07期
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma; metastasis; p53; proliferation; SPC25; WGCNA; LIVER-DISEASE; CANCER; LOOP;
D O I
10.1002/2211-5463.12872
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocellular carcinoma (HCC) is a common malignancy with poor prognosis and high mortality. To identify key genes associated with HCC and the underlying mechanisms, we performed weighted correlation network analysis (WGCNA) of potential key genes of HCC. We identified 17 key genes closely related to HCC by yellow module combined with PPI analysis. Verification of the role of these genes revealed that SPC25 knockdown results in a significant decrease in proliferation and metastasis of HCC cells and increased protein levels of components of the p53 pathway in vitro. In summary, we identified that SPC25 is a potential tumor-promoting factor in HCC and may act via the p53 pathway.
引用
收藏
页码:1261 / 1275
页数:15
相关论文
共 50 条
  • [1] SPC25 overexpression promotes tumor proliferation and is prognostic of poor survival in hepatocellular carcinoma
    Zhang, Baozhu
    Zhou, Qing
    Xie, Qiankun
    Lin, Xiaohui
    Miao, Wenqiang
    Wei, Zhaoguang
    Zheng, Tingting
    Pang, Zuoliang
    Liu, Haosheng
    Chen, Xi
    AGING-US, 2021, 13 (02): : 2803 - 2821
  • [2] Diagnostic and prognostic values of upregulated SPC25 in patients with hepatocellular carcinoma
    Yang, Xiaolin
    Sun, Hongzhi
    Song, Ying
    Yang, Li
    Liu, Haibo
    PEERJ, 2020, 8
  • [3] SPC25 promotes proliferation and stemness of hepatocellular carcinoma cells via the DNA-PK/AKT/Notch1 signaling pathway
    Yang, Jieying
    Huang, Yue
    Song, Mengjia
    Pan, Qiuzhong
    Zhao, Jingjing
    He, Junyi
    Ouyang, Dijun
    Yang, Chaopin
    Han, Yulong
    Tang, Yan
    Wang, Qijing
    He, Jia
    Li, Yongqiang
    Chen, Hao
    Weng, Desheng
    Xiang, Tong
    Xia, JianChuan
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (14): : 5241 - 5259
  • [4] SPC25 Promotes the Proliferation and Migration of Esophageal Carcinoma by Activating the MAPK/ERK Pathway
    Xiong, Rongsheng
    Xu, Ke
    Feng, Xiaoyan
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2023, 19 (03) : 424 - 430
  • [5] SPC25 promotes hepatocellular carcinoma metastasis via activating the FAK/PI3K/AKT signaling pathway through ITGB4
    Shi, Wen-Kai
    Shang, Qiao-Li
    Zhao, Yong-Fu
    ONCOLOGY REPORTS, 2022, 47 (05)
  • [6] The p53 family in hepatocellular carcinoma
    Kunst, Claudia
    Haderer, Marika
    Heckel, Sebastian
    Schlosser, Sophie
    Mueller, Martina
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 (06) : 632 - 638
  • [7] p53 gene therapy for pulmonary metastasis tumor from hepatocellular carcinoma
    Yu, Miao
    Chen, Wei
    Zhang, Jinshan
    ANTI-CANCER DRUGS, 2010, 21 (09) : 882 - 884
  • [8] TUMOR PROGRESSION IN HEPATOCELLULAR-CARCINOMA MAY BE MEDIATED BY P53 MUTATION
    TANAKA, S
    TOH, Y
    ADACHI, E
    MATSUMATA, T
    MORI, R
    SUGIMACHI, K
    CANCER RESEARCH, 1993, 53 (12) : 2884 - 2887
  • [9] Dulcitol suppresses proliferation and migration of hepatocellular carcinoma via regulating SIRT1/p53 pathway
    Lin, Xiao Lin
    Li, Kai
    Yang, Zhuo
    Chen, Baogui
    Zhang, Tao
    PHYTOMEDICINE, 2020, 66
  • [10] FOCUSING IN ON P53 IN HEPATOCELLULAR-CARCINOMA
    CARBONE, D
    HEPATOLOGY, 1991, 14 (04) : 742 - 744